CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

Endpoints News
Original article

Sanofi-backed Electra files for IPO to fund Phase 2/3 immunology drug

IPO/OfferingPositive
AI Analysis

Summary

Sanofi-backed Electra Therapeutics filed for IPO to begin trading on Nasdaq after Labor Day 2026, with proceeds intended to fund Phase 2/3 development of an immunology drug.

Clinical Trial Data

Phase

Phase 2/3

Importance:6/10
Sentiment:
0.50
IPOimmunologySanofi-backedPhase 2/3Nasdaq
Related Companies

Read the original article

Published by Endpoints News on August 31, 2026 2:28 PM

Read Original